01.11.2015 | Erratum
Erratum to: Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma
Erschienen in: Medical Oncology | Ausgabe 11/2015
Einloggen, um Zugang zu erhaltenExcerpt
The authors would like to make changes in the Results section as follows:-
To clarify the sentence in the discussion section: “we additionally recognize the potential confounding factor of differences in baseline Child class between both arms of the study”.
-
Figure 2: There is a typographical error in the age of the patient as it should be 57 and not 69 (born in 1953 and diagnosed in 2010).